1. ATTENDANCE FORM 6th NORTH WEST LIPID FORUM 11 th June 2013, 09:30-1600. YES, I am able to attend the meeting on Tuesday 11 th June 2013 To reserve your place, please complete the form and return at your earliest convenience to Mark Woodcock Email: mark.woodcock@cmft.nhs.ukmark.woodcock@cmft.nhs.uk Fax: Tel: 0161 276 8946 Post:0161 276 4684 CORRESPONDENCE DETAILS Name: ……………………………………………………………………………………………………………………... GP Surgery/Hospital:.…….…………………………………………………………………………………………. Role/Position:…………………………………………………………………………………………………………… Address: ………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………….. Postcode: ……………………………………………………………………………....................................... Contact Number: ……………………………………………………………………................................... Email Address: ………………………………………………………………………………………………………… Please state any dietary requirements: ……………………………………………………………………. Signature: ……………………………………………………………………………………………………………….. Date: …………………………………………………………………………………………………………………………

2. CPD accreditation 5 CPD applied for Invitation Organised by Dr Handrean Soran The organiser will not receive speaker honorarium or any other fee for chairing the sessions and organising the meeting This educational meeting has received funding from Sanofi to cover logistical costs (including catering, venue hire and speaker honoraria). Sanofi have had no input into the selection of speakers or topics for this meeting. 6 th NORTH WEST LIPID FORUM 11 th June 2013 6 th NORTH WEST LIPID FORUM 11 th June 2013 Date: Tuesday 11 th June2013 Venue: Hilton Manchester Airport Hotel, Manchester Airport, Outwood Lane, Manchester, M90 4WP University of Manchester The Centre for Endocrinology & Diabetes

3. 0915-0945Registration, Tea and Networking 0945-1000Welcome Session 1Chair: Professor Paul Durrington 1000-1050 HDL-C raising therapies: an update and a critical assessment. Professor Arnold von Eckardstein, Head of the Institute of Clinical Chemistry, University Hospital Zurich, Switzerland. 1050-1140 HDL functionality and LDL quality. Dr Handrean Soran. Consultant Physician and Endocrinologist, Central Manchester Foundation Trust, UK. 1140-1210Tea & Coffee, Networking Session 2 Chair: Dr Handrean Soran 1210-1300 Familial Hypercholesterolemia, beyond diagnosis and treatment: genetic cascade screening Dr Joep Defesche, Academic Medical Center, Amsterdam, Netherlands. 1300-1415Lunch Session 3Chair: Dr Lance Sandle 1415-1505 The importance of considering LDL-C as well as CVD risk if statins are to be most effective. Professor Paul Durrington, University of Manchester, UK. 1505-1555 Cost of not achieving LDL-C targets and new therapeutic LDL-C lowering options. Dr Dermot Neely, Director of the Laboratory services and Lead Consultant for the Lipid and Metabolic Outpatient Clinics, Royal Victoria Hospital, Newcastle, UK. 1550 Close Agenda